StoneX Group’s Inspire Corporate Bond ETF IBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-20,036
Closed -$477K 948
2025
Q1
$477K Sell
20,036
-2,553
-11% -$60.3K 0.03% 480
2024
Q4
$529K Buy
+22,589
New +$536K 0.03% 451
2023
Q1
Sell
-44,452
Closed -$1.02M 564
2022
Q4
$1.02M Sell
44,452
-3,347
-7% -$76.4K 0.15% 111
2022
Q3
$1.08M Buy
47,799
+5,222
+12% +$122K 0.2% 90
2022
Q2
$997K Buy
42,577
+601
+1% +$14.2K 0.16% 106
2022
Q1
$1.02M Sell
41,976
-244
-0.6% -$6.1K 0.1% 183
2021
Q4
$1.09M Buy
42,220
+2,297
+6% +$59.5K 0.13% 160
2021
Q3
$1.04M Buy
39,923
+260
+0.7% +$6.85K 0.15% 148
2021
Q2
$1.04M Buy
39,663
+1,801
+5% +$47K 0.15% 143
2021
Q1
$980K Buy
37,862
+6,328
+20% +$166K 0.18% 115
2020
Q4
$838K Buy
31,534
+4,268
+16% +$113K 0.18% 117
2020
Q3
$718K Buy
27,266
+3,147
+13% +$83.2K 0.23% 107
2020
Q2
$636K Buy
24,119
+1,623
+7% +$41.6K 0.24% 107
2020
Q1
$549K Buy
22,496
+13,432
+148% +$341K 0.29% 95
2019
Q4
$233K Buy
+9,064
New +$233K 0.1% 256

Other funds holding IBD

StoneX Group's IBD Position: Q2 2025 in Review

StoneX Group sold out of Inspire Corporate Bond ETF (IBD) in Q2 2025, closing a stake of 20,036 shares — an estimated $477K sold.

StoneX Group first reported a position in IBD in Q4 2019 and held it in 15 quarters. The position peaked at $1.09M in Q4 2021. 94 funds tracked by Wall St. Rank hold IBD as of Q2 2025.

  • StoneX Group reported no remaining Inspire Corporate Bond ETF position as of Q2 2025 after selling out during the quarter.
  • StoneX Group sold 20,036 Inspire Corporate Bond ETF shares in Q2 2025, an estimated $477K.
  • StoneX Group first reported a position in Inspire Corporate Bond ETF in Q4 2019 and held it in 15 quarters.
  • StoneX Group's Inspire Corporate Bond ETF position peaked at $1.09M in Q4 2021.
  • 94 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q2 2025.

Based on StoneX Group's 13F filing for Q2 2025, filed 13 Aug 2025.